Fabio is a postdoctoral fellow in the Synthetic Genomics programme at the Wellcome Sanger Institute.
Fabio will provide expertise in genome engineering and help build better models to study genetic diseases, such as cancer. While sited within David Adams group at Sanger, the programme involves associate faculty from leading groups in Synthetic Biology: Tom Ellis, Jason Chin and Patrick Cai
Quick links
My publications
Connect with me on Twitter
This, please. 👇With enough volume, the cost could be very low, similar to a handful of Sanger reads. Would make my DNA-jockeying so much easier. See also: https://octant.bio/blog/2019/9/29/octopus https://twitter.com/calinplesa/status/1379490821829849091
The more people do full plasmid seq, the easier it will be to pool and the more costs will come down. The days of Sanger and primer walking are numbered. https://twitter.com/SNPsaurus/status/1378197469566169089
Come join us! I’m looking for 2 #synbio postdocs to join my group as soon as possible to work on synthetic genomics. Eukaryote/Yeast experience desired.
Posts can be at @imperialcollege London or @sangerinstitute Cambridge depending on applicant preference. Please RT.
Pandora-seq: capturing all the small RNAs by removing modifications that usually prevent ligation and sequencing, reveals a new landscape including tsRNAs and rsRNAs; miRNA not the only/main class of small RNAs. Interesting thread. https://twitter.com/qichen_lab/status/1379094361418264579
Now alive! We develop PANDORA-seq @NatureCellBio to overcome RNA modifications that prevent small RNA detection in traditional RNA-seq, uncovering a new small RNA landscape that is in fact dominated by tsRNA/rsRNA, rather than miRNA in many tissues/cells👇
https://www.nature.com/articles/s41556-021-00652-7